Spheroid Culture of Mesenchymal Stem Cells

Compared with traditional 2D adherent cell culture, 3D spheroidal cell aggregates, or spheroids, are regarded as more physiological, and this technique has been exploited in the field of oncology, stem cell biology, and tissue engineering. Mesenchymal stem cells (MSCs) cultured in spheroids have enhanced anti-inflammatory, angiogenic, and tissue reparative/regenerative effects with improved cell survival after transplantation. Cytoskeletal reorganization and drastic changes in cell morphology in MSC spheroids indicate a major difference in mechanophysical properties compared with 2D culture. Enhanced multidifferentiation potential, upregulated expression of pluripotency marker genes, and delayed replicative senescence indicate enhanced stemness in MSC spheroids. Furthermore, spheroid formation causes drastic changes in the gene expression profile of MSC in microarray analyses. In spite of these significant changes, underlying molecular mechanisms and signaling pathways triggering and sustaining these changes are largely unknown.

[1]  K. Pienta,et al.  Intravascular metastatic cancer cell homotypic aggregation at the sites of primary attachment to the endothelium. , 2003, Cancer research.

[2]  P. Genever,et al.  Dynamic three-dimensional culture methods enhance mesenchymal stem cell properties and increase therapeutic potential. , 2010, Tissue engineering. Part C, Methods.

[3]  Yoshihide Hayashizaki,et al.  Histone H3 acetylated at lysine 9 in promoter is associated with low nucleosome density in the vicinity of transcription start site in human cell , 2006, Chromosome Research.

[4]  Todd C McDevitt,et al.  Pre-conditioning mesenchymal stromal cell spheroids for immunomodulatory paracrine factor secretion. , 2014, Cytotherapy.

[5]  K. Wood,et al.  Mesenchymal stromal cells: facilitators of successful transplantation? , 2010, Cell stem cell.

[6]  Vivian H. Fan,et al.  Epidermal Growth Factor as a Candidate for Ex Vivo Expansion of Bone Marrow–Derived Mesenchymal Stem Cells , 2006, Stem cells.

[7]  R E Durand,et al.  CELL CYCLE KINETICS IN AN IN VITRO TUMOR MODEL , 1976, Cell and tissue kinetics.

[8]  Y. Tintut,et al.  Mesenchymal stem cells and the artery wall. , 2004, Circulation research.

[9]  M. Zago,et al.  Multipotent mesenchymal stromal cells obtained from diverse human tissues share functional properties and gene-expression profile with CD146+ perivascular cells and fibroblasts. , 2008, Experimental hematology.

[10]  E. Unanue,et al.  Interleukin 1 is processed and released during apoptosis. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[11]  L. Griffith,et al.  Growth factor regulation of proliferation and survival of multipotential stromal cells , 2010, Stem Cell Research & Therapy.

[12]  Y. Sasai Next-generation regenerative medicine: organogenesis from stem cells in 3D culture. , 2013, Cell stem cell.

[13]  Christopher S. Chen,et al.  Cell shape, cytoskeletal tension, and RhoA regulate stem cell lineage commitment. , 2004, Developmental cell.

[14]  W. Birchmeier,et al.  Targeting MET in cancer: rationale and progress , 2012, Nature Reviews Cancer.

[15]  K. Tamama,et al.  Early Growth Response Genes Signaling Supports Strong Paracrine Capability of Mesenchymal Stem Cells , 2012, Stem cells international.

[16]  Yu Suk Choi,et al.  Interplay of Matrix Stiffness and Protein Tethering in Stem Cell Differentiation , 2014, Nature materials.

[17]  Douglas Hanahan,et al.  Signaling Vascular Morphogenesis and Maintenance , 1997, Science.

[18]  S. Pestka,et al.  MDA-7/IL-24: novel cancer growth suppressing and apoptosis inducing cytokine. , 2003, Cytokine & growth factor reviews.

[19]  R. Tuan,et al.  Identification and Functional Analysis of Candidate Genes Regulating Mesenchymal Stem Cell Self‐Renewal and Multipotency , 2006, Stem cells.

[20]  Gavin Thurston,et al.  Control of vascular morphogenesis and homeostasis through the angiopoietin–Tie system , 2009, Nature Reviews Molecular Cell Biology.

[21]  J. A. van der Laak,et al.  Circulating tumour tissue fragments in patients with pulmonary metastasis of clear cell renal cell carcinoma , 2009, The Journal of pathology.

[22]  M. Zago,et al.  Mesenchymal stem cells can be obtained from the human saphena vein. , 2005, Experimental cell research.

[23]  Yaojiong Wu,et al.  Epigenetic changes of mesenchymal stem cells in three-dimensional (3D) spheroids , 2014, Journal of cellular and molecular medicine.

[24]  G. Semenza Oxygen-dependent regulation of mitochondrial respiration by hypoxia-inducible factor 1. , 2007, The Biochemical journal.

[25]  Feng Zhao,et al.  Hypoxia enhances proliferation and tissue formation of human mesenchymal stem cells. , 2007, Biochemical and biophysical research communications.

[26]  C. Lengner,et al.  Oct4 expression is not required for mouse somatic stem cell self-renewal. , 2007, Cell stem cell.

[27]  R. Tuan,et al.  Mesenchymal stem cell therapy for attenuation of scar formation during wound healing , 2012, Stem Cell Research & Therapy.

[28]  Yufang Shi,et al.  How mesenchymal stem cells interact with tissue immune responses. , 2012, Trends in immunology.

[29]  Malin Parmar,et al.  Strengths and limitations of the neurosphere culture system , 2006, Molecular Neurobiology.

[30]  Regina Brunauer,et al.  Controversial issue: Is it safe to employ mesenchymal stem cells in cell-based therapies? , 2008, Experimental Gerontology.

[31]  P. Delafontaine,et al.  Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. , 2009, Cell stem cell.

[32]  E. Adamson,et al.  Epithelial layer formation in differentiating aggregates of F9 embryonal carcinoma cells , 1983, The Journal of cell biology.

[33]  T. Young,et al.  The influence of spheroid formation of human adipose-derived stem cells on chitosan films on stemness and differentiation capabilities. , 2012, Biomaterials.

[34]  S. Yamanaka,et al.  Epigenetic regulation in pluripotent stem cells: a key to breaking the epigenetic barrier , 2013, Philosophical Transactions of the Royal Society B: Biological Sciences.

[35]  P. Fisher,et al.  MDA-7/IL-24 as a cancer therapeutic: from bench to bedside , 2010, Anti-cancer drugs.

[36]  Peter A. Jones,et al.  Epigenetics in human disease and prospects for epigenetic therapy , 2004, Nature.

[37]  M. Fu,et al.  Early Growth Response Factor-1 Is a Critical Transcriptional Mediator of Peroxisome Proliferator-activated Receptor-γ1 Gene Expression in Human Aortic Smooth Muscle Cells* , 2002, The Journal of Biological Chemistry.

[38]  C. Toma,et al.  Fate Of Culture-Expanded Mesenchymal Stem Cells in The Microvasculature: In Vivo Observations of Cell Kinetics , 2009, Circulation research.

[39]  M. Ashraf,et al.  Transcriptional profiling of young and old mesenchymal stem cells in response to oxygen deprivation and reparability of the infarcted myocardium. , 2008, Journal of molecular and cellular cardiology.

[40]  P. Wilder-Smith,et al.  Three-dimensional spheroid culture of human gingiva-derived mesenchymal stem cells enhances mitigation of chemotherapy-induced oral mucositis. , 2012, Stem cells and development.

[41]  Nikolay Bazhanov,et al.  Aggregation of human mesenchymal stromal cells (MSCs) into 3D spheroids enhances their antiinflammatory properties , 2010, Proceedings of the National Academy of Sciences.

[42]  R. Foty A simple hanging drop cell culture protocol for generation of 3D spheroids. , 2011, Journal of visualized experiments : JoVE.

[43]  R. Gutiérrez,et al.  Adult stem cells and repair through granulation tissue. , 2009, Frontiers in bioscience.

[44]  D Eglin,et al.  Three-dimensional spheroids of adipose-derived mesenchymal stem cells are potent initiators of blood vessel formation in porous polyurethane scaffolds. , 2013, Acta biomaterialia.

[45]  R. Christensen,et al.  Mesenchymal stem cells, cancer challenges and new directions. , 2014, European journal of cancer.

[46]  D. Prockop,et al.  Human Mesenchymal Stem/Stromal Cells Cultured as Spheroids are Self‐activated to Produce Prostaglandin E2 that Directs Stimulated Macrophages into an Anti‐inflammatory Phenotype , 2012, Stem cells.

[47]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[48]  Peter R. Brink,et al.  Culturing of Human Mesenchymal Stem Cells as Three-dimensional Aggregates Induces Functional Expression of CXCR4 That Regulates Adhesion to Endothelial Cells* , 2008, Journal of Biological Chemistry.

[49]  P. Pinton,et al.  Calcium and apoptosis: ER-mitochondria Ca2+ transfer in the control of apoptosis , 2008, Oncogene.

[50]  H. Sorg,et al.  Wound Repair and Regeneration , 2012, European Surgical Research.

[51]  I. Sekiya,et al.  Expansion of Human Adult Stem Cells from Bone Marrow Stroma: Conditions that Maximize the Yields of Early Progenitors and Evaluate Their Quality , 2002, Stem cells.

[52]  N. Kulagina,et al.  Fibroblast precursors in normal and irradiated mouse hematopoietic organs. , 1976, Experimental hematology.

[53]  HighWire Press Philosophical Transactions of the Royal Society of London , 1781, The London Medical Journal.

[54]  G. Martin,et al.  Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[55]  Yoshiki Sasai,et al.  Cytosystems dynamics in self-organization of tissue architecture , 2013, Nature.

[56]  A. Friedenstein,et al.  Stromal stem cells: marrow-derived osteogenic precursors. , 1988, Ciba Foundation symposium.

[57]  Alan Wells,et al.  Epidermal Growth Factor (EGF) Treatment on Multipotential Stromal Cells (MSCs). Possible Enhancement of Therapeutic Potential of MSC , 2010, Journal of biomedicine & biotechnology.

[58]  T. Ma,et al.  Compaction, fusion, and functional activation of three-dimensional human mesenchymal stem cell aggregate. , 2015, Tissue engineering. Part A.

[59]  Christopher S. Chen,et al.  Emergence of Patterned Stem Cell Differentiation Within Multicellular Structures , 2008, Stem cells.

[60]  R. Kaufman,et al.  Calcium trafficking integrates endoplasmic reticulum function with mitochondrial bioenergetics. , 2014, Biochimica et biophysica acta.

[61]  K. Mizuseki,et al.  Directed differentiation of telencephalic precursors from embryonic stem cells , 2005, Nature Neuroscience.

[62]  Michael R Rosen,et al.  Mesenchymal Stem Cells Support Migration, Extracellular Matrix Invasion, Proliferation, and Survival of Endothelial Cells In Vitro , 2007, Stem cells.

[63]  Meijing Wang,et al.  HIGH PASSAGE NUMBER OF STEM CELLS ADVERSELY AFFECTS STEM CELL ACTIVATION AND MYOCARDIAL PROTECTION , 2006, Shock.

[64]  G. Lepperdinger,et al.  Mesenchymal stem cell aging , 2005, Experimental Gerontology.

[65]  J. Campisi,et al.  Replicative Senescence: An Old Lives' Tale? , 1996, Cell.

[66]  W. Weimar,et al.  Mesenchymal stem cells induce an inflammatory response after intravenous infusion. , 2013, Stem cells and development.

[67]  G. Shurin,et al.  Early growth response-2 signaling mediates immunomodulatory effects of human multipotential stromal cells. , 2014, Stem cells and development.

[68]  N. Nishiyama,et al.  3D spheroid culture system on micropatterned substrates for improved differentiation efficiency of multipotent mesenchymal stem cells. , 2009, Biomaterials.

[69]  Shan-hui Hsu,et al.  Substrate-dependent gene regulation of self-assembled human MSC spheroids on chitosan membranes , 2013, BMC Genomics.

[70]  G. Bergers,et al.  The bone marrow constitutes a reservoir of pericyte progenitors , 2006, Journal of leukocyte biology.

[71]  Danny Reinberg,et al.  Molecular Signals of Epigenetic States , 2010, Science.

[72]  D. Prockop,et al.  Concise Review: Two negative feedback loops place mesenchymal stem/stromal cells at the center of early regulators of inflammation , 2013, Stem cells.

[73]  S. Hsu,et al.  Spheroid formation of mesenchymal stem cells on chitosan and chitosan-hyaluronan membranes. , 2011, Biomaterials.

[74]  S. Hsu,et al.  The calcium-dependent regulation of spheroid formation and cardiomyogenic differentiation for MSCs on chitosan membranes. , 2012, Biomaterials.

[75]  Sten Orrenius,et al.  Calcium: Regulation of cell death: the calcium–apoptosis link , 2003, Nature Reviews Molecular Cell Biology.

[76]  Joelle Dulong,et al.  Clinical-grade mesenchymal stromal cells produced under various good manufacturing practice processes differ in their immunomodulatory properties: standardization of immune quality controls. , 2013, Stem cells and development.

[77]  M. Arufe,et al.  Differentiation of synovial CD‐105+ human mesenchymal stem cells into chondrocyte‐like cells through spheroid formation , 2009, Journal of cellular biochemistry.

[78]  C. Sen,et al.  Differential roles of hypoxia inducible factor subunits in multipotential stromal cells under hypoxic condition , 2011, Journal of cellular biochemistry.

[79]  H. Hosick,et al.  Glycosaminoglycan synthesis by mammary tumor spheroids. , 1982, Biochemical and biophysical research communications.

[80]  Arnold I Caplan,et al.  All MSCs are pericytes? , 2008, Cell stem cell.

[81]  Tai-Horng Young,et al.  Short‐Term Spheroid Formation Enhances the Regenerative Capacity of Adipose‐Derived Stem Cells by Promoting Stemness, Angiogenesis, and Chemotaxis , 2013, Stem cells translational medicine.

[82]  J. Carlsson,et al.  Proliferation and viability in cellular spheroids of human origin. , 1978, Cancer research.

[83]  Peter Kuhn,et al.  Characterization of circulating tumor cell aggregates identified in patients with epithelial tumors , 2012, Physical biology.

[84]  T. Waddell,et al.  Mesenchymal stromal cells augment CD4+ and CD8+ T-cell proliferation through a CCL2 pathway. , 2013, Cytotherapy.

[85]  T. Ma,et al.  Three-dimensional aggregates of mesenchymal stem cells: cellular mechanisms, biological properties, and applications. , 2014, Tissue engineering. Part B, Reviews.

[86]  M. Kaufman,et al.  Establishment in culture of pluripotential cells from mouse embryos , 1981, Nature.

[87]  Paul D. Kessler,et al.  Human Mesenchymal Stem Cells Differentiate to a Cardiomyocyte Phenotype in the Adult Murine Heart , 2002, Circulation.

[88]  H. Dertinger,et al.  A comparative study of post-irradiation growth kinetics of spheroids and monolayers. , 1975, International journal of radiation biology and related studies in physics, chemistry, and medicine.

[89]  O. Ringdén,et al.  Analysis of Tissues Following Mesenchymal Stromal Cell Therapy in Humans Indicates Limited Long‐Term Engraftment and No Ectopic Tissue Formation , 2012, Stem cells.

[90]  P. Friedl,et al.  Interstitial cell migration: integrin-dependent and alternative adhesion mechanisms , 2009, Cell and Tissue Research.

[91]  D. Ingber,et al.  Forty-Year Journey of Angiogenesis Translational Research , 2011, Science Translational Medicine.

[92]  C. Sen,et al.  Differentiation of bone marrow mesenchymal stem cells into the smooth muscle lineage by blocking ERK/MAPK signaling pathway. , 2008, Stem cells and development.

[93]  Jacques Galipeau,et al.  The mesenchymal stromal cells dilemma--does a negative phase III trial of random donor mesenchymal stromal cells in steroid-resistant graft-versus-host disease represent a death knell or a bump in the road? , 2013, Cytotherapy.

[94]  Hwan-You Chang,et al.  Recent advances in three‐dimensional multicellular spheroid culture for biomedical research , 2008, Biotechnology journal.

[95]  R. Pedersen,et al.  Human embryonic stem cells , 2005, Stem Cell Reviews.

[96]  Tetsurou Yamamoto,et al.  Salivary gland progenitor cells induced by duct ligation differentiate into hepatic and pancreatic lineages , 2003, Hepatology.

[97]  W. Mueller‐Klieser Three-dimensional cell cultures: from molecular mechanisms to clinical applications. , 1997, American journal of physiology. Cell physiology.

[98]  R. Hale,et al.  In vitro characterization of scaffold-free three-dimensional mesenchymal stem cell aggregates , 2014, Cell and Tissue Research.

[99]  S. Badylak,et al.  A perivascular origin for mesenchymal stem cells in multiple human organs. , 2008, Cell stem cell.

[100]  N. Kiyokawa,et al.  A microfabricated scaffold induces the spheroid formation of human bone marrow-derived mesenchymal progenitor cells and promotes efficient adipogenic differentiation. , 2011, Tissue engineering. Part A.

[101]  D. Banerjee,et al.  Macrophage-Associated Mesenchymal Stem Cells Assume an Activated, Migratory, Pro-Inflammatory Phenotype with Increased IL-6 and CXCL10 Secretion , 2012, PloS one.

[102]  F. Grinnell,et al.  Adsorption characteristics of plasma fibronectin in relationship to biological activity. , 1981, Journal of biomedical materials research.

[103]  Christopher S. Chen,et al.  Forms, forces, and stem cell fate. , 2014, Current opinion in cell biology.

[104]  Weian Zhao,et al.  To grab the stroma by the horns: From biology to cancer therapy with mesenchymal stem cells , 2013, Oncotarget.

[105]  J. Morgan,et al.  Advances in the formation, use and understanding of multi-cellular spheroids , 2012, Expert opinion on biological therapy.

[106]  A. Uccelli,et al.  Mesenchymal stem cells in health and disease , 2008, Nature Reviews Immunology.

[107]  R. Sutherland,et al.  Effects of intercellular contact on repair of radiation damage. , 1972, Experimental cell research.

[108]  A I Caplan,et al.  In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. , 1998, Experimental cell research.

[109]  Shay Soker,et al.  Role of growth factors and endothelial cells in therapeutic angiogenesis and tissue engineering. , 2006, Current stem cell research & therapy.

[110]  T. Ma,et al.  Endogenous extracellular matrices enhance human mesenchymal stem cell aggregate formation and survival , 2013, Biotechnology progress.

[111]  P. Fisher,et al.  MDA-7/IL-24: multifunctional cancer killing cytokine. , 2014, Advances in experimental medicine and biology.

[112]  S. O'Kane,et al.  Scar-free healing: from embryonic mechanisms to adult therapeutic intervention. , 2004, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[113]  J. Karp,et al.  Mesenchymal stem cells: immune evasive, not immune privileged , 2014, Nature Biotechnology.

[114]  R. Zhao,et al.  Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. , 2008, Cell Stem Cell.

[115]  J. Berg,et al.  An argument against a role for Oct4 in somatic stem cells. , 2007, Cell stem cell.

[116]  R. Pochampally Colony forming unit assays for MSCs. , 2008, Methods in molecular biology.

[117]  R. Sutherland,et al.  Growth and radiation survival characteristics of V79-171b Chinese hamster cells: a possible influence of intercellular contact. , 1973, Radiation research.

[118]  U. Landmesser,et al.  Stem and progenitor cell-based therapy in ischaemic heart disease: promise, uncertainties, and challenges. , 2011, European heart journal.

[119]  D. Prockop Marrow Stromal Cells as Stem Cells for Nonhematopoietic Tissues , 1997, Science.

[120]  A M Mackay,et al.  Chondrogenic differentiation of cultured human mesenchymal stem cells from marrow. , 1998, Tissue engineering.

[121]  A. Caplan Why are MSCs therapeutic? New data: new insight , 2009, The Journal of pathology.

[122]  H. Cedar,et al.  Linking DNA methylation and histone modification: patterns and paradigms , 2009, Nature Reviews Genetics.

[123]  M. Krampera,et al.  Mesenchymal stromal cell ‘licensing’: a multistep process , 2011, Leukemia.

[124]  J. Carlsson,et al.  The influence of oxygen on viability and proliferation in cellular spheroids. , 1979, International journal of radiation oncology, biology, physics.

[125]  J. Yuhas,et al.  Growth fraction as the major determinant of multicellular tumor spheroid growth rates. , 1978, Cancer research.

[126]  R. Sutherland,et al.  A multi-component radiation survival curve using an in vitro tumour model. , 1970, International journal of radiation biology and related studies in physics, chemistry, and medicine.

[127]  D. Prockop,et al.  The CD34-like protein PODXL and alpha6-integrin (CD49f) identify early progenitor MSCs with increased clonogenicity and migration to infarcted heart in mice. , 2009, Blood.

[128]  E Ruoslahti,et al.  New perspectives in cell adhesion: RGD and integrins. , 1987, Science.

[129]  Todd C. McDevitt,et al.  Materials as stem cell regulators. , 2014, Nature materials.

[130]  V. Goldberg,et al.  The Chondrogenic Potential of Human Bone-Marrow-Derived Mesenchymal Progenitor Cells* , 1998, The Journal of bone and joint surgery. American volume.

[131]  E. J. Lee,et al.  Spherical bullet formation via E-cadherin promotes therapeutic potency of mesenchymal stem cells derived from human umbilical cord blood for myocardial infarction. , 2012, Molecular therapy : the journal of the American Society of Gene Therapy.

[132]  Byung-Soo Kim,et al.  Transplantation of cord blood mesenchymal stem cells as spheroids enhances vascularization. , 2012, Tissue engineering. Part A.

[133]  R. Sutherland,et al.  Dependence of the radiation response of an in vitro tumor model on cell cycle effects. , 1973, Cancer research.

[134]  Sohail Ahmed,et al.  The culture of neural stem cells , 2009, Journal of cellular biochemistry.

[135]  Melissa A. Kinney,et al.  Stiffening of human mesenchymal stem cell spheroid microenvironments induced by incorporation of gelatin microparticles. , 2012, Journal of the mechanical behavior of biomedical materials.

[136]  D. Prockop,et al.  Dynamic compaction of human mesenchymal stem/precursor cells into spheres self‐activates caspase‐dependent IL1 signaling to enhance secretion of modulators of inflammation and immunity (PGE2, TSG6, and STC1) , 2013, Stem cells.

[137]  J. Carlsson,et al.  Demonstration of an extracellular matrix in multicellular tumor spheroids. , 1984, Cancer research.

[138]  J. Campisi From cells to organisms: can we learn about aging from cells in culture? , 2001, Experimental Gerontology.